Re: [爆卦] 賽諾菲和葛蘭素失敗的疫苗1/2期實驗已刪文

看板Gossiping作者going70 (心靜止水)時間3年前 (2021/05/31 16:23)推噓6(9推 3噓 8→)

留言20則, 16人參與討論串2/3 (看更多)

: 六月解盲，陳時中部長只說看抗體反應 (從一期結果猜測抗體過關的機會不低) : 猜測沒提預防效果是因為不容易達到統計上顯著差異(受試者少且盛行率低) : 如果抗體及預防感染都顯著，解盲成功當然成功 : 如果預防感染未達顯著，抗體顯著，專家會議會如何判定呢？ May 19, 2021 摘錄自PTT Stock板作者 zzahoward (FDA這篇是在說抗體檢測不能判斷免疫能力或本身對病毒的抗性) 原文標題： FDA In Brief: FDA Advises Against Use of SARS-CoV-2 Antibody Test Results to Evaluate Immunity or Protection From COVID-19, Including After Vaccination 原文連結： https://tinyurl.com/34znv66p 原文內容： “The FDA is reminding the public of the limitations of COVID-19 antibody, or serology, testing and providing additional recommendations about the use of antibody tests in people who received a COVID-19 vaccination. Antibody tests can play an important role in identifying individuals who may have been exposed to the SARS-CoV-2 virus and may have developed an adaptive immune response. However, antibody tests should not be used at this time to determine immunity or protection against COVID-19 at any time, and especially after a person has received a COVID-19 vaccination. The FDA will continue to monitor the use of authorized SARS-CoV-2 antibody tests for purposes other than identifying people with an adaptive immune response to SARS-CoV-2 from a recent or prior infection.” 大致翻譯如下 FDA認為可以用SARS-CoV-2抗體來進行辨識接觸病毒歷史但FDA表示抗體並不能代表免疫力或保護力(減少重症) "尤其是使用過COVID-19之疫苗後" 國產疫苗二期只有中和抗體效價的數據 (補充，中和抗體和總抗體是不同的東西) 也就是說，依照此數據推估出來的效力或是保護力，都無法經過檢驗或承認 -- 收錄一下結論一個沒有效力數據的疫苗要怎麼進行戰略調度呢? 以上用FDA的最新資料回答一下 -- 佛劍語錄：徘徊世間的無主幽魂掙扎在生死之間是怎樣的的苦處吾非自地獄而回而是生在無間之中捨身如來無間輪迴佛劍之路不由分說小活佛：聖行者相信天命嗎? 佛劍分說：相信 -- ※ 發信站: 批踢踢實業坊(ptt.cc), 來自: 117.56.185.21 (臺灣) ※ 文章網址: https://www.ptt.cc/bbs/Gossiping/M.1622449419.A.C36.html

噓

05/31 16:24, 3年前 , 1^F

05/31 16:24, 1^F

→

05/31 16:24, 3年前 , 2^F

05/31 16:24, 2^F

→

douge

05/31 16:24, 3年前 , 3^F

05/31 16:24, 3^F

→

askey